Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Avita Medical (RCEL) just unveiled an announcement.
AVITA Medical, Inc. successfully conducted its 2024 Annual Meeting virtually, with stockholders electing all seven proposed directors and ratifying the appointment of Grant Thornton LLP as the independent auditor. Additionally, stockholders approved equity awards for non-executive directors and the CEO, consisting of both restricted stock units and options. The non-binding advisory vote also saw stockholders endorse the compensation of the company’s named executive officers, reflecting a proactive governance and compensation strategy that aligns with shareholder interests.
Find detailed analytics on RCEL stock on TipRanks’ Stock Analysis page.